3/20
07:25 am
jnj
Origin Materials and HP Embalagens enter PET cap distribution deal [Yahoo! Finance]
Low
Report
Origin Materials and HP Embalagens enter PET cap distribution deal [Yahoo! Finance]
3/20
06:58 am
jnj
Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business [Yahoo! Finance]
Low
Report
Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business [Yahoo! Finance]
3/20
04:01 am
jnj
Contact Lenses and Solutions Market to Reach USD 38.09 Billion by 2032 Amid Rising Vision Care Demand and Technological Advancements, Reports Vyansa Intelligence [Yahoo! Finance]
Low
Report
Contact Lenses and Solutions Market to Reach USD 38.09 Billion by 2032 Amid Rising Vision Care Demand and Technological Advancements, Reports Vyansa Intelligence [Yahoo! Finance]
3/19
09:51 pm
jnj
GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer [Yahoo! Finance]
Low
Report
GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer [Yahoo! Finance]
3/19
03:54 pm
jnj
ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi? [Yahoo! Finance]
Neutral
Report
ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi? [Yahoo! Finance]
3/19
02:14 pm
jnj
$500 a Month in Passive Income Is Closer Than You Think With These 4 Dividend ETFs [Yahoo! Finance]
Low
Report
$500 a Month in Passive Income Is Closer Than You Think With These 4 Dividend ETFs [Yahoo! Finance]
3/19
01:22 pm
jnj
Jim Cramer on Johnson & Johnson: “It Should Have Gone Higher, But It Just Shows You How Hard It Is to Buck Stagflation Theories” [Yahoo! Finance]
Low
Report
Jim Cramer on Johnson & Johnson: “It Should Have Gone Higher, But It Just Shows You How Hard It Is to Buck Stagflation Theories” [Yahoo! Finance]
3/19
10:44 am
jnj
Johnson & Johnson (JNJ) had its price target raised by Barclays PLC from $217.00 to $234.00. They now have an "equal weight" rating on the stock.
Low
Report
Johnson & Johnson (JNJ) had its price target raised by Barclays PLC from $217.00 to $234.00. They now have an "equal weight" rating on the stock.
3/19
08:14 am
jnj
Johnson & Johnson announces U.S. FDA approved Icotyde [Yahoo! Finance]
Low
Report
Johnson & Johnson announces U.S. FDA approved Icotyde [Yahoo! Finance]
3/19
07:31 am
jnj
From pilot mania to portfolio discipline: how the best companies are escaping AI purgatory [Fortune]
Low
Report
From pilot mania to portfolio discipline: how the best companies are escaping AI purgatory [Fortune]
3/19
04:52 am
jnj
Crossbow raises $77M for new cancer immunotherapies [Yahoo! Finance]
Low
Report
Crossbow raises $77M for new cancer immunotherapies [Yahoo! Finance]
3/18
08:39 pm
jnj
Argenx Data At AAN Puts VYVGART Neuromuscular Upside In Focus [Yahoo! Finance]
Low
Report
Argenx Data At AAN Puts VYVGART Neuromuscular Upside In Focus [Yahoo! Finance]
3/18
05:19 pm
jnj
ICOTYDE Approval Adds New Growth Angle To Johnson & Johnson Valuation Story [Yahoo! Finance]
Low
Report
ICOTYDE Approval Adds New Growth Angle To Johnson & Johnson Valuation Story [Yahoo! Finance]
3/18
03:01 pm
jnj
Johnson & Johnson (JNJ) was given a new $253.00 price target by Morgan Stanley.
Low
Report
Johnson & Johnson (JNJ) was given a new $253.00 price target by Morgan Stanley.
3/18
02:07 pm
jnj
Johnson & Johnson (JNJ) had its "overweight" rating reaffirmed by Morgan Stanley.
Low
Report
Johnson & Johnson (JNJ) had its "overweight" rating reaffirmed by Morgan Stanley.
3/18
12:34 pm
jnj
J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections [Yahoo! Finance]
Low
Report
J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections [Yahoo! Finance]
3/18
11:07 am
jnj
J&J's new psoriasis pill to rival AbbVie's Skyrizi: BNP Paribas [Seeking Alpha]
Low
Report
J&J's new psoriasis pill to rival AbbVie's Skyrizi: BNP Paribas [Seeking Alpha]
3/18
08:41 am
jnj
US FDA approves J&J's oral psoriasis pill [Yahoo! Finance]
Low
Report
US FDA approves J&J's oral psoriasis pill [Yahoo! Finance]
3/18
08:30 am
jnj
Former CMS Leader Elizabeth Fowler Joins Humata Health to Advance Innovation in AI-Driven Medical Review [Yahoo! Finance]
Low
Report
Former CMS Leader Elizabeth Fowler Joins Humata Health to Advance Innovation in AI-Driven Medical Review [Yahoo! Finance]
3/18
08:07 am
jnj
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide [Yahoo! Finance]
Low
Report
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide [Yahoo! Finance]
3/18
07:49 am
jnj
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
Low
Report
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
3/17
07:16 pm
jnj
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]
Low
Report
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]
3/17
02:30 pm
jnj
American College of Cardiology to Host New Orleans Community Health Fair [Yahoo! Finance]
Low
Report
American College of Cardiology to Host New Orleans Community Health Fair [Yahoo! Finance]
3/17
12:30 pm
jnj
Johnson & Johnson (JNJ) had its price target raised by HSBC Holdings plc from $265.00 to $280.00. They now have a "buy" rating on the stock.
Low
Report
Johnson & Johnson (JNJ) had its price target raised by HSBC Holdings plc from $265.00 to $280.00. They now have a "buy" rating on the stock.
3/17
12:18 pm
jnj
Why One Analyst Thinks Johnson & Johnson Reaches $280 [Yahoo! Finance]
Low
Report
Why One Analyst Thinks Johnson & Johnson Reaches $280 [Yahoo! Finance]